A close scrutiny of ASX listed companies leads to a few companies having good potential. These are the growing companies to invest in
Bioxyne Limited (ASX: BXN)
Bioxyne Limited (ASX: BXN) has reported exceptional growth in its second-quarter financial results for the period ending 31 December 2024, showing a significant 77% increase in revenue compared to Q1, and a remarkable 310% surge compared to Q2 FY2024. For the first half of FY2025, the company recorded $12.6 million in revenue, marking a 267% increase from the previous half. This growth was driven by several key factors, including major contracts, an expanding customer base, and a broader range of products. The company has also demonstrated strong cash flow management, achieving $1.5 million in positive operating cash flow, supported by cash receipts totaling $7.4 million. By the end of December 2024, Bioxyne had a solid cash position of $2.7 million. To accommodate rising demand, Bioxyne has been actively increasing its manufacturing capacity, with plans to launch expanded production capabilities for its BLS pastilles products by mid-February 2025. This upgrade is expected to triple the current output for pastilles and further boost production of other product lines.
Bioxyne remains focused on scaling its operations to capture additional market share, particularly for its Dr Watson pharmaceutical products in Australia and health and wellness offerings in Europe. The company is also preparing to introduce its proprietary PCC probiotic product into its global distribution channels. With regulatory approvals expected soon for exports to the UK and the completion of a GMP manufacturing facility in Europe, Bioxyne is well-positioned for further international expansion. Investment in plant and equipment, security vaults, and leasehold improvements amounted to $1.3 million during the first half of FY2025. As a result, the company is confident in its ability to achieve continued revenue growth, with projections indicating an increase in product category revenues between 30% to 50% over the next two quarters. Bioxyne is committed to maintaining its focus on high-quality standards while managing costs effectively and ensuring profitability through the remainder of FY2025.
Marmota Limited (ASX: MEU)
Marmota Limited (ASX: MEU) has reported development across its key projects, reinforcing its position as a high-potential, multi-commodity explorer. At the Aurora Tank gold project, recent drilling has delivered high-grade, near-surface mineralization, with standout intercepts including 7m @ 14 g/t Au from 31m depth in Hole 24ATRC075, featuring an exceptional 50 g/t Au assay between 32m and 33m. To validate the result and ensure quality control, the company conducted Bulk Leach Extractable Gold (BLEG) testwork, analyzing multiple sub-samples from the same interval. The confirmation of the ultra-high-grade assay, with an average grade increase of over 73%, further underscores the robustness of the deposit.
Marmota, one of the best penny stocks to invest in right now is advancing its Muckanippie Heavy Minerals (HM) titanium discovery (EL 6166), where initial metallurgical testwork has delivered exceptional heavy mineral concentrate grades. Every discovery hole has returned high-grade HM mineralization from surface, confirming the potential for a significant large-scale titanium resource. Early assays indicate TiO2 grades exceeding 10%, reinforcing Muckanippie’s potential as a high-value titanium project. Given titanium’s critical importance in aerospace, defense, energy storage, semiconductors, and medical applications, this discovery represents a major strategic opportunity. Marmota has announced an 89-hole follow-up drill program to expand the resource and assess its economic potential. Meanwhile, at Campfire Bore, early-stage exploration has delineated a high-grade gold zone with open extensions to the south, indicating strong upside potential. This project could serve as a complementary asset alongside Aurora Tank, supporting a broader gold development strategy.
With high-grade gold results at Aurora Tank, a growing titanium discovery at Muckanippie, and expansion drilling planned across both projects, Marmota is positioned for a transformational 2025. The company’s diversified resource base, spanning both precious and critical minerals, provides substantial upside for investors. Ongoing drilling and metallurgical testwork will be key catalysts, with the potential to unlock significant value across its gold and titanium assets.
Source: Company’s Report
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
